Prevention of Corticosteroid-induced Glucose Intolerance

• Status: Unknown status
• Trial end date: 2015-10-01
• Target enrollment: 0
• Participant gender: All

Summary

Glucose intolerance is frequent and serious complication of corticosteroid therapy. the aim of the study is to examine the hypothesis that co treatment with rosiglitazone can prevent glucose intolerance in patients treated with corticosteroids.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hadassah Medical Organization
• Treatments: Rosiglitazone

Criteria

Inclusion Criteria:

• corticosteroid treatment

Exclusion Criteria:

• congestive heart failure pedal edema